Five-year cure of cervical cancer treated using californium-252 neutron brachytherapy
Journal Article
·
· Am. J. Clin. Oncol.; (United States)
Female pelvic carcinoma is one of the common malignancies seen at the University of Kentucky Medical Center and often presents in an advanced stage. In 1976, the authors began to test californium-252 neutron brachytherapy (NT) for its efficacy for control of primary and recurrent advanced uterine, cervix, and vaginal cancers. The first protocol used was 5000-5500 rad of whole pelvis irradiation followed by 1-2 Cf-252 insertions using a single tandem placed in the utero-cervico-vaginal region. Of 27 patients with primary carcinomas treated, 10 are alive and well 5 year later (37%). Two of two recurrent tumors were locally controlled but failed later. These patients had advanced cervical, vaginal, or endometrial carcinomas. In 1977, a transitional year, treatment of only unfavorable stages and presentations with NT was initiated. Similar results were obtained with NT as compared to conventional photon therapy (PT). Further improvement in treatment results can be anticipated as NT brachytherapy is used for advanced cancer therapy by more effective treatment schedules and radiation doses. Cf-252 can be used as a radium substitute and achieved similar rates of tumor control and 5-year survivals. 21 references, 2 tables.
- Research Organization:
- Univ. of Kentucky Medical Center, Lexington
- OSTI ID:
- 5998031
- Journal Information:
- Am. J. Clin. Oncol.; (United States), Journal Name: Am. J. Clin. Oncol.; (United States) Vol. 7; ISSN AJCOD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix
Clinical trial for advanced cervico-vaginal pelvic carcinomas using californium CF-252 fast neutron therapy: report of early responses
Feasibility study of Californium-252 for the therapy of stage IV cervical cancer
Journal Article
·
Wed Apr 15 00:00:00 EDT 1987
· Cancer (Philadelphia); (United States)
·
OSTI ID:6591813
Clinical trial for advanced cervico-vaginal pelvic carcinomas using californium CF-252 fast neutron therapy: report of early responses
Journal Article
·
Sun Nov 30 23:00:00 EST 1980
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6680995
Feasibility study of Californium-252 for the therapy of stage IV cervical cancer
Journal Article
·
Wed Jun 15 00:00:00 EDT 1988
· Cancer (Philadelphia); (United States)
·
OSTI ID:7152979
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ACTINIDE ISOTOPES
ACTINIDE NUCLEI
ALPHA DECAY RADIOISOTOPES
BODY
CALIFORNIUM 252
CALIFORNIUM ISOTOPES
CARCINOMAS
DISEASES
DOSES
EVEN-EVEN NUCLEI
FEMALE GENITALS
HEAVY NUCLEI
ISOTOPES
MEDICINE
NEOPLASMS
NEUTRON THERAPY
NUCLEAR MEDICINE
NUCLEI
ORGANS
PATIENTS
RADIATION DOSES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SURVIVAL TIME
THERAPY
UTERUS
YEARS LIVING RADIOISOTOPES
62 RADIOLOGY AND NUCLEAR MEDICINE
ACTINIDE ISOTOPES
ACTINIDE NUCLEI
ALPHA DECAY RADIOISOTOPES
BODY
CALIFORNIUM 252
CALIFORNIUM ISOTOPES
CARCINOMAS
DISEASES
DOSES
EVEN-EVEN NUCLEI
FEMALE GENITALS
HEAVY NUCLEI
ISOTOPES
MEDICINE
NEOPLASMS
NEUTRON THERAPY
NUCLEAR MEDICINE
NUCLEI
ORGANS
PATIENTS
RADIATION DOSES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SURVIVAL TIME
THERAPY
UTERUS
YEARS LIVING RADIOISOTOPES